Trials / Unknown
UnknownNCT02837640
Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa
The Effect of L-Dopa on the Progression of Retinitis Pigmentosa
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Beirut Eye Specialist Hospital · Academic / Other
- Sex
- All
- Age
- 10 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effect of L-Dopa on the progression of retinitis pigmentosa.
Detailed description
Retinitis pigmentosa is a group of progressive hereditary diseases that diffusely affects the functioning of photoreceptors and the pigment epithelium. It may be speculated that a protective effect on the pigment epithelium, as it is supposed for L-Dopa, can slow the progression of the disease or even lead to an, at least transient, improvement of visual functions. To evaluate the effect of L-Dopa on retinitis pigmentosa progression, visual acuity, electroretinogram and visual field will be preformed regularly.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | levodopa-carbidopa | sinemet 200/50 1/2 tablet b.i.d. for 2 days and then t.i.d for 6 months |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2017-06-01
- Completion
- 2021-06-01
- First posted
- 2016-07-19
- Last updated
- 2016-07-19
Locations
1 site across 1 country: Lebanon
Source: ClinicalTrials.gov record NCT02837640. Inclusion in this directory is not an endorsement.